The number of M1 macrophages, which include CD68+TLR2+ and CD68+NOS2+ cells, were increased in BLM-treated scleroderma skin, and EchA co-treatment reduced the number of M1 macrophages (Figure 3A,D). Here, CD68 is linked to scleroderma.